Fiera Capital Corp Natera, Inc. Transaction History

Fiera Capital Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$86.26 - $119.0 $3.39 Million - $4.67 Million	-39,270 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$100.17 - $126.36 $46,579 - $58,757	-465 Reduced 1.17%	39,270 $4.38 Million
Q2 2021 Aug 11, 2021	SELL	$86.05 - $119.72 $242,747 - $337,730	-2,821 Reduced 6.63%	39,735 $1.98 Million
Q1 2021 May 11, 2021	BUY	$91.47 - $124.36 $134,918 - $183,431	1,475 Added 3.59%	42,556 $4.32 Million
Q4 2020 Feb 09, 2021	SELL	$66.66 - $111.74 $38,862 - $65,144	-583 Reduced 1.4%	41,081 $4.09 Million
Q3 2020 Nov 12, 2020	SELL	$45.89 - $72.67 $52,268 - $82,771	-1,139 Reduced 2.66%	41,664 $3.01 Million
Q2 2020 Aug 07, 2020	SELL	$26.36 - $49.86 $40,146 - $75,936	-1,523 Reduced 3.44%	42,803 $2.14 Million
Q1 2020 May 08, 2020	BUY	$17.27 - $40.17 $765,510 - $1.78 Million	44,326 New	44,326 $1.32 Million

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.